Mary Ann Liebert, Inc., publishers

Smokers who crushed computer-simulated cigarettes in a psychosocial treatment program in a virtual reality environment had significantly reduced nicotine dependence and higher rates of tobacco abstinence than smokers participating in the same program

Doctor of the Heart: My Life in Medicine is the autobiography of Isadore Rosenfeld, MD, world-renowned cardiologist, best-selling author, and popular television commentator, published by Mary Ann Liebert, Inc., (www.liebertpub.com/heart).

If thrillers like The Da Vinci Code and The Lost Symbol have enthralled you, then GEN’s latest mind-boggling challenge will certainly stimulate your brain.

Therapeutic Hypothermia, a new online open access peer-reviewed journal, will focus on medical treatment which lowers a patient's body temperature to help reduce the risk of ischemic injury to tissues following a period of insufficient blood flow.

Guidelines derived from a recent Consensus Conference, including recommendations on the role of healthcare providers in the assurance of quality spiritual care to patients in a palliative care setting, are published in Journal of Palliative Medicine

Rosalind Franklin Society announced a new campaign to ensure that women are included in awards consideration from the beginning. When the Geoffrey Beene Gives Back Foundation unveiled its first “Rock Stars of Science,” all 13 honorees were men.

An innovative technique called L.I.F.E. imaging used successfully to detect bacteria in frozen Antarctic lakes could have exciting implications for demonstrating signs of life in the polar regions of Mars

The commercial failure of Exubera led other companies to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. Does this signal defeat for efforts to deliver insulin via the lungs?

Risk factors for metabolic syndrome, such as obesity, high blood pressure, and elevated blood lipid levels, can increase a person’s healthcare costs nearly 1.6-fold, or about $2,000 per year. For each risk factor those costs rise an average of 24%.

The recipients of The 2009 Lasker Awards, announced today, represent the dramatic advances achieved in biotechnology research that have led to a revolutionary cancer treatment and the tremendous promise of stem cell therapy for regenerative medicine.